Registry for patients with Status Epilepticus in critical care
Status Epilepticus in the Critically Ill Patients
This study is trying to gather information about patients with Status Epilepticus in critical care to see how they are treated and what outcomes they have.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ictal Group Academic / other |
| Locations | 20 sites (Angoulême and 19 other locations) |
| Trial ID | NCT03457831 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a prospective registry for patients experiencing Convulsive and Non-Convulsive Status Epilepticus (SE) in critical care settings. It involves collecting comprehensive data on patient demographics, seizure characteristics, treatment timelines, and outcomes, including vital status and Glasgow Outcome Scale scores at various time points. The study will utilize standardized forms to ensure consistency in data collection across multiple hospitals. The goal is to better understand the circumstances and treatment of SE in critically ill patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years and older who are experiencing Status Epilepticus.
Not a fit: Patients under 18 years of age or those with postanoxic status epilepticus will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management and outcomes of critically ill patients suffering from Status Epilepticus.
How similar studies have performed: While there have been studies on Status Epilepticus, this registry approach is relatively novel and aims to fill gaps in existing knowledge.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * SE defined as 5 min or more of (i) continuous clinical and/or electrographic seizure activity or (ii) recurrent seizure activity without recovery (returning to baseline) between seizures. * age \>= 18 years Exclusion Criteria: * age \< 18 years * postanoxic status epilepticus
Where this trial is running
Angoulême and 19 other locations
- CH Angouleme - Service de réanimation polyvalente — Angoulême, France (Recruiting)
- CH de Beauvais - Service de réanimation polyvalente — Beauvais, France (Recruiting)
- CH de Bethune - Service de Réanimation et Surveillance continue — Beuvry, France (Recruiting)
- Centre Hospitalier Universitaire Régional — Brest, France (Recruiting)
- CH Brive La Gaillarde - Service de réanimation - USC — Brive-la-Gaillarde, France (Recruiting)
- CH de Cannes — Cannes, France (Recruiting)
- CH Public du Cotentin - Service de Réanimation - Médecin intensive — Cherbourg, France (Recruiting)
- CHU Beaujon — Clichy, France (Recruiting)
- Hopitaux Universitaires Henri Mondor - Service d'anesthésie et des réanimations chirurgicales, Unité d'anesthésie-réanimation chirurgical cardiovasculaire — Créteil, France (Recruiting)
- Centre Hospitalier de Dieppe — Dieppe, France (Recruiting)
- Centre Hospitalier Universitaire de Dijon — Dijon, France (Recruiting)
- CH de La Rochelle - Service de réanimation - USC — La Rochelle, France (Recruiting)
- Intensive Care Unit - Versailles Hospital — Le Chesnay, France (Recruiting)
- Hôpital privé Jacques Cartier - Service de réanimation médico chirurgicale — Massy, France (Recruiting)
- Groupe Hospitalier Sud Ile de France - Service de Réanimation - Médecin intensive — Melun, France (Recruiting)
- Centre Hospitalier Universitaire de Nantes — Nantes, France (Recruiting)
- Groupe Hospitalier Paris Saint Joseph - Service de réanimation médico chirurgicale — Paris, France (Recruiting)
- HP Claude Galien - Service de Réanimation Polyvalente — Quincy-sous-Sénart, France (Recruiting)
- Centre hospitalier de Roanne - Service de Réanimation - Soins continus — Roanne, France (Recruiting)
- Centre Hospitalier de Toulon — Toulon, France (Recruiting)
Study contacts
- Principal investigator: stephane LEGRIEL, MD — Ictal Group
- Study coordinator: stephane LEGRIEL, MD
- Email: slegriel@ch-versailles.fr
- Phone: +33139639717
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.